Magnetic hyperthermia enhance the treatment efficacy of peri-implant osteomyelitis

R E S E A R C H A R T I C L E

Open Access

Magnetic hyperthermia enhance the

treatment efficacy of peri-implant

osteomyelitis

Chih-Hsiang Fang

, Pei-I Tsai

, Shu-Wei Huang

, Jui-Sheng Sun

, Jenny Zwei-Chieng Chang

,

Hsin-Hsin Shen

, San-Yuan Chen

, Feng Huei Lin

, Lih-Tao Hsu

and Yen-Chun Chen

Abstract

Background: When bacteria colony persist within a biofilm, suitable drugs are not yet available for the eradication of biofilm-producing bacteria. The aim of this study is to study the effect of magnetic nano-particles-induced hyperthermia on destroying biofilm and promoting bactericidal effects of antibiotics in the treatment of osteomyelitis. Methods: Sixty 12-weeks-old male Wistar rats were used. A metallic 18G needle was implanted into the bone marrow cavity of distal femur after the injection of Methicillin-sensitive Staphylococcus aureus (MSSA). All animals were divided into 5 different treatment modalities. The microbiological evaluation, scanning electron microscope examination, radiographic examination and then micro-CT evaluation of peri-implant bone resorption were analyzed.

Results: The pathomorphological characteristics of biofilm formation were completed after 40-days induction of osteomyelitis. The inserted implants can be heated upto 75 °C by magnetic heating without any significant thermal damage on the surrounding tissue. We also demonstrated that systemic administration of vancomycin [VC (i.m.)] could not eradicate the bacteria; but, local administration of vancomycin into the femoral canal and the presence of magnetic nanoparticles hyperthermia did enhance the eradication of bacteria in a biofilm-based colony. In these two groups, the percent bone volume (BV/TV: %) was significantly higher than that of the positive control.

Conclusions: For the treatment of chronic osteomyelitis, we developed a new modality to improve antibiotic efficacy; the protection effect of biofilms on bacteria could be destroyed by magnetic nanoparticles-induced hyperthermia and therapeutic effect of systemic antibiotics could be enhanced.

Keywords: Peri-implant osteomyelitis, Magnetic nanoparticle, Hyperthermia, Biofilm Background

Infection of bone and soft tissue is one of the biggest problems in orthopedic daily practice, which mostly leads to progressive inflammation and even bone destruc-tion [1]. Osteomyelitis is the infecdestruc-tion and inflammadestruc-tion of bone and bone marrow tissue, usually begins as an acute infection, but it may evolve into a chronic condition. It can be subdivided into hematogenous or posttraumatic spread of bacteria, whereas the incidence of posttraumatic osteomyelitis is around 80% [2]. The treatment of chronic

osteomyelitis is a challenging problem, since germs with variable drug sensitivities exist. The most common pathogens are coagulase negative staphylococci and Staphylococcus aureus [3]. There is still no evidence-based guidance on the treatment of chronic osteomyelitis and there is no single-treatment regimen or surgical pro-cedure that is appropriate for all patients [2]. Besides the use of antibiotics, sufficient debridement seems to be the most important therapy for osteomyelitis [2].

In the presence of necrotic bone, a biofilm can develop and reduce the efficacy of antibiotic therapy by 103folds [4]. Bacteria may persist in a biofilm-based colony or be intra-cellularly concealed within osteoblasts, these charac-teristics render bacteria a greater resistance to the host’s immune response and antibiotic therapy [5]. Biofilm is

* Correspondence:drjssun@gmail.com;jennyzc@ms3.hinet.net

4

Department of Orthopedic Surgery, College of Medicine, National Taiwan University, No. 1, Ren-Ai Rd, Taipei 10051, Taiwan, Republic of China

7_{School of Dentistry, College of Medicine, National Taiwan University, No 1}

Chang-Te Street, Taipei 10048, Taiwan

Full list of author information is available at the end of the article

© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

any group of microorganisms in which cells stick to each other and adhere to a surface. These adherent cells are frequently embedded within a self-produced matrix of extracellular polymeric substance (EPS) [6]. Suitable drugs are not yet available for the eradication of such biofilm-producing bacteria.

Iron is an essential but potentially hazardous biometal. Mammalian cells require sufficient amounts of iron to satisfy metabolic needs or to accomplish specialized functions. Iron is an essential trace nutrient required for the active sites of many electron transfer and oxygen transport enzymes. In contrast, iron is also a catalyst for reactive oxygen species (ROS). Organisms must acquire iron but also must protect against oxidative damage. Fer-ritin is a naturally designed nanomachine for disposing cellular irons. Ferritin sequesters iron and maintains it in a biologically safe form. Ferritin also releases stored metals in response to cell needs. Thus, ferritin plays im-portant roles in detoxification and reservation, and is vital for maintaining iron homeostasis in living cells. Fer-ritin genes are ubiquitously present among bacteria, plants, and animals, suggesting that they are essential genes for most organisms [7–9]. The iron oxide particle size of these agents varies widely, and influences their physicochemical and pharmacokinetic properties, and thus their clinical applications. Iron oxide nanocrystals (IONPs) are superparamagnetic. Many IONPs, including superparamagnetic iron oxides (SPIOs), are encapsulated by hydrophilic polymers to improve the stability and solubility. SPIOs have been used in clinical applications as a contrast agent for magnetic resonance imaging (MRI) [10, 11]. IONPs can be safely administered in the body because they do not raise concerns of heavy metal uptake and accumulation.

The healing effect of heat has been well-known since ancient times, it have been used to cure cancer [12] and infection [13]. The heating of biological tissue can be achieved by several physical mechanisms including microwave irradiation [14, 15], Ohmic heating [16], op-tical laser irradiation [17] or water bath heating [18, 19]. With these heating methods, it remains a challenge to control the spatial extent of heating in tissue. Magnetic particles hyperthermia improves the precision of heating by embedding the heating source into tissue and heating it using an external alternating magnetic field [20]. Many clinical trials have demonstrated the efficacy and safety of magnetic hyperthermia for prostate cancer and gli-omas; patients can tolerate this therapy without discom-fort or serious side effects [21–23]. However, there is no research for magnetic hyperthermia in the treatment of osteomyelitis. The aim of this study is to study the heat-ing effect of magnetic nanoparticles-induced hyperther-mia on destroying biofilm and promoting antibiotic efficacy for the treatment of peri-implant osteomyelitis.

Mthods

Synthesis of Fe3O4magnetic nanoparticles

All chemicals, including 1,2-tetradecanediol, dibenzyl ether solution, oleic acid (C17H33COOH, technical grade 90%),

oleylamine (C18H35NH2, technical grade 70%), Iron(III)

acetylacetonate were obtained from (Fe(acac)3,

Sigma-Aldrich, Inc., St. Louis, MO, USA). Fe3O4 magnetic

nanoparticles were synthesized according to the follow-ing procedure. First, 2.0 mmole of Fe(acac)3, 10 mmole

1,2-tetradecanediol solution was added into 15 mL of dibenzyl ether solution, mixed with stabilizer and dis-persant [containing 6 mmole oleic acid (C17H33COOH)

and 6 mmole oleylamine (C18H35NH2)], stirring for

30 min at 130 °C and then then under a blanket of ni-trogen, heated to reflux (290 °C) for 1 h. The dibenzyl ether which containing 0.03 M Fe3+ acetylacetonate mixture solution was added drop-wise under vigorous mechanical stirring (2000 rpm) for 30 min. The color of the suspension turned to black immediately. The sus-pension was cooled to room temperature by removing the heat source, ethanol (40 ml) was added to the mixture and a black material was precipitated and separated via centri-fugation. The black product was dissolved in hexane in the presence of oleic acid (~0.05 mL) and oleyl amine (~0.05 mL). Centrifugation (6000 rpm, 10 min) was ap-plied to remove any undispersed residue (almost none). The product, 6 nm Fe3O4nanoparticles, was then

pre-cipitated with ethanol, centrifuged (6000 rpm, 10 min) to remove the solvent and redispersed into hexane. The precipitate was washed three times with doubly distilled water and then several times with ethanol. The super-natant solution was removed from the precipitate after decantation. Finally, the 6 nm Fe3O4magnetic

nanopar-ticles were dispersed with small amount of oleic acid (~0.05 mL) and oleylamine (~0.05 mL) and stored with hexane in a stoppered bottle for further use. The size and morphologies of products were characterized by transmission electron microscopy (TEM) of HITACHI TEM H-7500 microscope (HITACHI, Japan) with 200 mesh carbon film coated copper grid. The crystal struc-tures of samples were recorded using a Rigaku X-ray powder diffractometer (Geigerflex; Tokyo, Japan).

Alternating magnetic field (AMF) generator

An AMF was generated by a vertical coil with an inner diameter of 6.5 cm (Coil 1.5 A, 30 turns), driven by a transistor inverter (HOT SHOT; Ameritherm, New York, USA) operated at a frequency of 100 kHz and electric current (EC) 250 A which is capable of generating a 20G magnetic field. Thermal images were taken using a thermograph (infrared thermal imaging camera InfReC R300SR; Nippon Avionics, Tokyo, Japan). Temperature was also measured by using a thermograph.

The magnetic properties of Fe3O4 nanoparticles

were analyzed by superconducting quantum interfer-ence device (SQUID, MPMS-XL7, Quantum Design, USA) at temperature 2 and 300 K with an applied field between −20 and 20 kOe; moreover, zero field cooling (ZFC) and field cooling (FC) measurement were carried out at 500 Oe to determine the blocking temperature (Tb). The magnetic properties analyses were used to

deter-mine the blocking temperature (Tb), the temperature above which the magnetic property will change from ferri-magnetism to superparaferri-magnetism, and magnetization curve which showed the saturation magnetization value for examining the feasibility of temperature increase within the AMF.

In vitro hyperthermia effect

To evaluate the heating effect in vitro, the magnetic nano-particles were placed in the bottom of a 1 mL eppendorf tube filled with 0.5 mL PBS. Each loaded eppendorf tube was set in the center of a two-turning copper coil (25 mm in diameter) in an alternating magnetic field (AMF, Power cube 64/900, ~ 750–1150 kHz, Ceia Co., Arezzo, Italy). Heat generation from the samples was determined by measuring the temperature change of PBS every 10 s with an optical fiber probe (STF-1 m) connected with the fluor-optic thermometer (I652, Luxtron, USA). The in vitro hyperthermia effect of the samples were carried out in the AMF as mentioned above and the eppendorf tubes were filled with 0.5 mL FBS. The heating process was per-formed for 30 s and the temperature was maintained at 74–75 °C by automatically switching an on/off device of the AMF.

Animal model and surgical procedure

The experimental protocol was approved by the Institu-tional Animal Care and Use Committee of Medical Col-lege, National Taiwan University (Taipei, Taiwan). Sixty male 12 weeks-old Wistar rats (300 ± 20 g were purchased from the Laboratory Animal Center, Medical College, Na-tional Taiwan University (Taipei, Taiwan) and acclimated under standard laboratory conditions at 22 ± 2 °C and 50 ± 10% humidity. Standard rat chow and water were available ad libitum during the acclimation period. Animals were anesthetized by Zoletil (15-18 mg/kg) and Rompun (0.05 ml/kg). Surgical interventions were performed under strict sterile conditions. The surgical area was shaved and disinfected with iodine, and a midline knee incision was made, followed by medial parapatellar arthrotomy and lat-eral patella subluxation to expose the knee joint. In the pilot study (24 rats), the osteomyelitis model was built by implanting metallic 18G needle into the bone marrow cav-ity of distal femur after injecting 105CFU/50 μl bacterial suspension of Methicillin-sensitive Staphylococcus aureus BCRC10451 (MSSA); while in the sham-operated negative

control rats, metallic 18G needle was implanted without injection of MSSA (Fig. 1.). The strain used in this study,S. aureus BCRC10451 (MSSA), was cultivated overnight at 37 °C in brain heart infusion (BHI) broth (Sigma-Aldrich, Inc., St. Louis, MO, USA). The arthrotomy was closed using non-resorbable sutures in an interrupted pattern and then the skin was closed with resorbable suture. Intramus-cular injection of cefazolie (20 mg/kg, Purzer Pharmaceut-ical Co., Ltd., Taipei, Taiwan) was used for postoperative prophylaxis. The formation of biofilm were confirmed by histological staining and scanning electron microscopy. In the pilot study, the rats were randomized to either 10, 20, 30 or 40 days endpoints to check the progression of histo-pathological change of osteomyelitis. Since the biofilm dor-mation was quite clear at 20 days after MSSA injection, we selected this time point for the following experiment to evaluate treatment efficacy of hyperthermia.

The evaluation for the treatment efficacy of magnetic hyperthermia, different treatment modalities (total volume 0.5 cm3) was implanted into the bone marrow cavity of distal femur by a metallic 23G needle. All of the 30 animals were divided into 5 groups (Fig. 2): Group I: osteomyelitis positive control without treatment; Group II: osteomyelitis treated with intramuscular injection of vancomycin [VC (20 mg/ kg, i.m., Sandoz Inc., Princeton, NJ, USA)]; Group III: osteomyelitis treated with both intramuscular and femur cavity injection of vancomycin [VC (20 mg/kg, i.m.) + VC (20 mg/ kg, f.c)]; Group IV: osteomyelitis treated with both intramuscular injection of vancomycin and magnetic particles [VC(20 mg/kg, i.m.) + M]; Group V: osteomyelitis treated with intra-muscular injection of vancomycin and magnetic parti-cles hyperthermia [VC(20 mg/kg, i.m.) + M + IOHA]. Animals from each group were sacrificed by overdose of pentobarbital at 40 days after surgery.

Microbiological evaluation

Bacteriology swabs from the subcutaneous tissue and the implant site were obtained from all operation sites at the time of sacrifice. Swabs were moistened with one drop (20μl) of sterile PBS, evenly streaked onto agar plate. The samples were incubated for 48 h at the 37 °C under anaer-obic conditions. After 48 h’ incubation, the media were analyzed by conventional bacteriological techniques.

Scanning electron microscope examination and histological staining

The morphology of biofilm was observed by scanning electron microscopy (SEM; Topcon ABT-60, Tokyo, Japan). Briefly, the specimens were fixed with 4% para-formaldehyde (PFA) for 2 h and 2% osmium tetroxide (OsO4) solution for 1 h, dehydrated in a graded series

Fig. 1 Sequence of surgical procedures and X-ray image and Animal models for induction of osteomyelitis. Left: Sequence of surgical procedures and X-ray image. Osteomyelitis animal models used 18G needle as implant and injecting methicillin-sensitive Staphylococcus aureus suspension into bone marrow canal as an infection model. The X-ray image showed that needle completely inserted into femur of rats. Right: Animal models for induction of osteomyelitis. a Uninfected group (left leg); (b) Uninfected group (right leg); (c) Osteomyelitis group (left leg): 10 days after induction of infection; (d) Osteomyelitis group (right leg): 10 days after induction of infection; (e) Osteomyelitis group (left leg): 40 days after induction of infection; (f) Osteomyelitis group (right leg): 40 days after induction of infection

Fig. 2 Flow Chart of experimental design

and sputter-coated with gold to a thickness film before observation.

For hematoxylin and eosin (HE) staining, randomly chosen femur from the osteomyelitis group was fixed in 5% formaldehyde for two days, decalcified by 5% nitric acid solution, and then embedded with paraffin. The tis-sues were cut and coronally sliced into 7 μm sections until use. Slices were stained with haematoxylin/eosin. Congo red staining and gram’s staining were also per-formed using the same sliced tissues. Six visual fields from each section were randomly selected and observed under light microscopy.

Radiographic examination and micro-CT (computed tomography) evaluation

For radiographic evaluation, the soft tissue attached to the femur was remove, the rat femurs were examined by X-rays (Siemens, Germany). After radiologic examination, implants were removed and then assessed three dimen-sionally using Micro-CT (SkyScan 1176; Bruker Micro-CT, Kontich, Belgium) [24]. Datasets were reconstructed using CTvox 2.4 software for fast volumetric reconstruction, 2D/3D quantitative analysis and realistic 3D visualization. The tissue volume (TV: mm3), bone volume (BV: mm3) were recorded and then percent bone volume (BV/TV: %) was analyzed.

Statistical analysis

All results were presented as means ± standard deviation (SD). Statistical analysis was performed for all the quan-titative results using ANOVA test, the post hoc analysis used was Tukey’s honestly significant difference. The

overall analysis was performed by the IBM Statistics SPSS 16.0 and the statistical significance in each test was set atp < 0.05.

Results

Transmission electron microscope (TEM) examination of Fe3O4 magnetic nanoparticles was illustrated in the

Fig. 3. In the presence of small amounts of stabilizer and dispersant, hydrophilic and stable Fe3O4 nanoparticles

were synthesized (Fig. 3a); the formation of F3O4

nano-particles did not significantly affected by the changes in the injection temperature (Fig. 3b).

The crystal structure of Fe3O4nanoparticles was

con-firmed by XRD spectroscopy. As shown in Fig. 4a, the diffraction peaks at 2θ = 30.4°, 35.5°, and 43.2° can be well indexed to (220), (311), and (400) planes of the in-verse cubic spinel structure of Fe3O4 (JCPDS card no.

75–1610), respectively; according to the reflection peak positions and relative intensities, which confirms the for-mation of the Fe3O4 nanoparticles. The sample formed

under a magnetic field is pure Fe3O4without any

impur-ity phases [1, 25]. Figure 4b was the hysteresis loops of Fe3O4 nanoparticles at room temperature. As shown in

Fig. 4b, the hysteresis loops show that saturation magne-tizations of Fe3O4was 1.0 emu/g at the field of 1.5 KOe,

and the absence of coercivity and remanence indicates that the as-prepared Fe3O4has superparamagnetic

prop-erties above the blocking temperature. The TEM image in Fig. 4c shows that the average size of as-synthesized Fe3O4magnetite nanoparticles is ca. 16 nm with narrow

size distribution.

Fig. 3 Transmission Electron Microscope (TEM) examination of Fe3O4magnetic nanoparticles. Upper: TEM of F3O4Nanoparticles: Effect of different

amounts of stabilizer and dispersant. a 80μL, b 160 μL, and c 400 μL surfactant. Lower: TEM of F3O4Nanoparticles: Effect of different temperature on

Heat production is determined by the magnetic prop-erties of Fe3O4nanoparticles, its concentration, and the

strength of the AMF. Therefore, we examined the heating effect of AMF on medium containing Fe3O4

nanoparti-cles by thermography. The temperature increased time-dependently, and we adjusted the required temperature dependent on the concentration of Fe3O4nanoparticles

and the magnitude of the electric current used to gen-erate AMF to gengen-erate a temperature of 75 °C, and we adopted these conditions for the subsequent assays. In this study, the inserted implants can be heated to 75 °C by magnetic heating (Fig. 5). When the implants were heated to 75 °C either for 90 s or 120 s (each 30 s heating with a rest for 1 min), there were no significant thermal damage noted in these two testing conditions (Fig. 5).

All animals survived after the surgical procedures and no postoperative skin infection or fever was observed. Figure 6 showed the histological, histopathological stain-ing and microbiology assessment from osteomyelitis rats after 40 days infection (Fig. 6. Left upper). In this figure, uninfected group possesses normal trabecular patterns of cancellous bone (upper: Fig. 6 Left upper: A and B); while in the acute suppurative changes of osteomyelitis, there was devitalized lamellar bone with scalloped edges and absence of stainable osteocytes and osteoblasts, edema and granulocytic infiltration of surrounding tissues are obvious (middle: Fig. 6 Left upper: C-E). In the chronic

osteomyelitis, there was the irregular fragment of devita-lized bone surrounded by dense fibrous tissue heavily infil-trated by plasma cells, lymphocytes, and only a few granulocytes (lower: Fig. 6 Left upper: F-H).

In the histopathological staining, we verified the patho-morphological characteristics of our infected rat femur (Fig. 6 Left lower). As shown here, GRAM-staining re-vealed the presence of bacteria within the defect site as Gram (+) Staphylococcus aureus bacteria could be de-tected (Fig. 6 Left lower: B and C). Cango red staining (Fig. 6 Left lower: A) and SEM image (Fig. 6 Left lower: D) showed the biofilm forming completed after 40 days induction of osteomyelitis.

All smears taken from the experimental sites showed characteristic accretion ofS. aureus infection as depicted in Fig. 3. In the control group, there is few characteristic CFUs on the agar plate (Fig. 6 Right: A). On the other hand, tissue from the affected area, intramedullary liquid from the infected femur and the implants from the in-fected animals all showed characteristic growth of CFUs on agar plates (Fig. 6 Right: B-D).

After the inoculation of Staphylococcus aureus, tissue necrosis with active inflammation and even biofilm for-mation were clearly demonstrated in all groups; while, the biofilm formation were found both at the surface of the inserted pin and the inner surface of bony trabeculae. Different treatment modalities did not change the

Fig. 4 Characteristics of Fe3O4nanoparticles. a The XRD pattern of the Fe3O4nanoparticles. b Room-temperature magnetization curves for FO111019-P

and FO111019-h. Magnetic hysteresis curves measured at room temperature for the samples prepared by a hydrothermal process (square: FO111019-h, dot: FO111019-p) showed the super-paramagnetic characteristics. c The crystal structure of Fe3O4nanoparticles prepared at the injection temperature of

290 °C (TEM). The average diameter of particles is 16 nm

histopathological features of the induced osteomyelitis; while massive necrosis of tissue was observed in the group V which was treated with intramuscular injection of vancomycin and magnetic particles hyperthermia [VC(i.m.) + M + IOHA] (Fig. 7).

In our study, we demonstrated that systemic adminis-tration of vancomycin [VC (i.m.)] did not show any ef-fect on eradication of the bacteria when compared with the positive control group; similar event observed in the presence of magnetic nanoparticles [VC (i.m.) + M]. But, local administration of vancomycin into the femoral canal [VC (i.m.) + VC (f.c)] did enhance the eradication of bacteria; similar event was observed in the presence of magnetic nanoparticles when magnetic field was ap-plied [VC (i.m.) + M + IOHA] (Fig. 8).

In the peri-implant osteomyelitis, systemic administration of vancomycin [VC (i.m.)] with/or without the presence of magnetic nanoparticles [VC (i.m.) + M] did not affect the percent bone volume; but, when local administration of vancomycin into the femoral canal [VC (i.m.) + VC (f.c)] or magnetic field was applied in the presence of magnetic nanoparticles [VC (i.m.) + M + IOHA]. The percent bone volume (BV/TV) was significantly higher than that of the positive control (Fig. 9).

Discussion

Currently, there are no evidence-based guidelines in terms of the treatment of chronic osteomyelitis [2]. It is difficult to achieve complete remission, some studies re-port a failure rates of 20–60% [26]. The aim of treatment is to improve quality of life through either a curative or a palliative strategy. Curative management strategies usually comprise of a combination of complex surgical procedures and tailored adjuvant antibiotic therapy [27]; on the other hand, palliative treatment strategies are less invasive and typically involve to the use of chronic sup-pressive antibiotic therapy [28].

Recognizing the importance of the host’s physiological status during formulation of a treatment plan, Cierny and Mader revolutionized the approach to chronic osteomyelitis through the publication of their clinical staging system in 1985 (Table 1) [29]. In our model, there is seriously immune response in bone marrow and synovial fluid. Our results exhibit that, after S. aureus bacterial inoculation and incubation, a steady infection in femur was generated (Fig. 6 Left upper). According to this classification system, we created a localized type of osteomyelitis in hosts with uncompromised immune sys-tems, corresponding to type IIIA osteomyelitis. In the

Fig. 5 Tissue damage after thermotherapy (H & E staining). Left: The needle at 75 °C for 90 s by magnetic heating (each 30 s heating with a rest for 1 min), Right: The needle at 75 °C for 120 s by magnetic heating (each 30 s heating with a rest for 1 min). There were no significant thermal damage noted in these two testing conditions

histopathological staining, we verified the pathomorpho-logical characteristics of our infected rat femur and the biofilm formation was completed after 40 days induction of osteomyelitis (Fig. 6 Left lower), with characteristic accretion of Staphylococcus aureus infection presents at different tissues obtained from the affected area (Fig. 6 Right).

Hyperthermia (HT) is a minimally invasive method for cancer therapy in which the target tissues are annealed to about 42–46 °C. Heat treatment in such a temperature range is cytotoxic for tumor cells because of their disorganized and compact vascular structure that promotes an unfavorable microenvironment inside them. Although HT is a promising approach to cancer therapy, the inevitable technical problem with hyperther-mia is the difficulty in heating only the local tumor re-gion to the intended temperature without damaging the

surrounding healthy tissue [30]. Magnetic nanoparticles are increasingly used for clinical applications such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia. Magnetic nanoparticles (MNPs) have been used for HT treatment in an attempt to overcome this obstacle [23, 31]. The magnetic nanoparticles have been focus on many research recently because they pos-sess attractive properties which could be potential used in biomedicine, tissue specific targeting, magnetic reson-ance imaging, defect sensor and environmental remedi-ation, etc. [32–36].

In this study, the inserted implants can be heated to 75 °C by magnetic heating; while, there were no signifi-cant thermal damage noted in this testing condition (Fig. 5) Due to magnetic particles had better dispersion, magnetic nanoparticles (MNPs) heating sources was re-lated to the better distribution of heating intensity in

Fig. 6 Histological, histopathological staining and microbiology assessment from osteomyelitis rats after 40 days infection. Left upper: Histological sections with H&E staining. Upper: Uninfected group, magnification a 40 × and b 1000 ×; Middle: Osteomyelitis 10 days after induction of infection, magnification c 40 ×, d and e 1000 ×; Lower: Osteomyelitis 40 days after induction of infection, magnification f 40 ×, g and h 1000 ×. In this figure, uninfected group possesses normal trabecular patterns of cancellous bone (upper: a and b); while in the acute suppurative changes of osteomyelitis, there is devitalized lamellar bone with scalloped edges and absence of stainable osteocytes and osteoblasts, edema and granulocytic infiltration of surrounding tissues are obvious (middle: c-e). In the chronic osteomyelitis, there is the irregular fragment of devitalized bone surrounded by dense fibrous tissue heavily infiltrated by plasma cells, lymphocytes, and only a few granulocytes (lower: f-h). Left lower: Histopathological staining. a Cango red staining, b H&E staining, c Gram staining and d SEM morphology, respectively. As shown here, GRAM-staining revealed the presence of bacteria within the defect site as Gram (+) Staphylococcus aureus bacteria could be detected (b and c). Cango red staining (a) and SEM image (d) showed the biofilm forming completed after 40 days induction of osteomyelitis. Magnification of pictures are 1000 ×. Right: Microbiology assessment from osteomyelitis rats after 40 days infection. Specimens streaked onto agar plate for: a Sterilized PBS as control group; b Tissue from the affected area; c Intramedullary liquid from the affected femur; d Implants from the affected animals. All smears taken from the experimental sites showed characteristic accretion of S. aureus infection. In the control group, there is few characteristic CFUs on the agar plate (a). On the other hand, tissue from the affected area, intramedullary liquid from the infected femur and the implants from the infected animals all showed characteristic growth of CFUs on agar plates (b-d)

tissue [37, 38]. We did observed that after inoculation of Staphylococcus aureus, tissue necrosis with active in-flammation and even biofilm formation were clearly demonstrated in all groups; the biofilm formation were found both the at the surface of the inserted pin and the inner surface of bony trabeculae. Different treatment

modalities did not change the histopathological features of the induced osteomyelitis; while massive necrosis of tis-sue was observed in the group V which was treated with intramuscular injection of vancomycin and magnetic par-ticles hyperthermia [VC(i.m.) + M + IOHA] (Fig. 7). As shown above, since this parameter did not cause tissue damage, we implied that the induced hyperthermia can enhance the destruction ofStaphylococcus aureus.

In this study, rat osteomyelitis model was built by implanting metallic needle into the marrow cavity of distal femur after injecting 108CFU/0.5 ml of bacterial suspension. In this model, intramuscular injection of vancomycin [VC (i.m.)] did not show any effect to treat osteomyelitis. In the group of intramuscular injection of vancomycin with magnetic environment also could not make biofilm collapse and even to enhance bacteria growth [VC (i.m.) + M]. By raising the temperature of im-plant, adding magnetic nanoparticles to support hyper-thermia that could destroy biofilm and enhance efficacy of vancomycin significantly [VC (i.m.) + M + IOHA] (Fig. 8). In the peri-implant osteomyelitis, local administration of vancomycin into the femoral canal [VC (i.m.) + VC (f.c)] or magnetic field application in the presence of magnetic nanoparticles [VC (i.m.) + M + IOHA] did prevent the bone loss associated with infection (Fig. 9).

Fig. 8 Colony-forming unit of implants and the affected area under different treatment modalities. Systemic administration of vancomycin [VC (i.m.)] did not show any better effect on eradication of the bacteria; similar event observed in the presence of magnetic nanoparticles [VC (i.m.) + M]. Local administration of vancimycin into the femoral canal [VC (i.m.) + VC (f.c)] did enhance the eradication of bacteria; similar event observed in the presence of magnetic nanoparticles when magnetic field was applied [VC (i.m.) + M + IOHA]

Fig. 7 Histological and scanning electron microscope examination of different treatment modalities for osteomyelitis rats after 40 days infection. After inoculation of Staphylococcus aureus, tissue necrosis with active inflammation and even biofilm formation was clearly demonstrated in all groups; while, the biofilm formation were found both the at the surface of the inserted pin and the inner surface of bony trabeculae. Group I: osteomyelitis positive control without treatment; Group II: osteomyelitis treated with intramuscular injection of vancomycin [VC (i.m.)]; Group III: osteomyelitis treated with both intramuscular and femur cavity injection of vancomycin [VC (i.m.) + VC (f.c)]; Group IV: osteomyelitis treated with both intramuscular injection of vancomycin and magnetic particles [VC(i.m.) + M]; Group V: osteomyelitis treated with intramuscular injection of vancomycin and magnetic particles hyperthermia [VC(i.m.) + M + IOHA]. Animals from each group were sacrificed by overdose of pentobarbital at 40 days after surgery. *(red): biofilm-like ECM; **(black): necrosis with inflammation; ***(green): inflammation

A number of animal models were created in order to study the treatment effects of bacterial infections. Staphylococcus aureus strain for bacterial inoculation was used in almost all of them, because this is the most common pathogen in the setting of osteomyelitis [3, 39]. Furthermore, rats and rabbits were used in most studies because they are big enough to create stable long bone infections without giant efforts; while on the other hand they are small enough to be housed and handled easily [40–43]. Bone and intramedullary bacterial infections are one of the most serious complications of the surgical repair of fractures. Treatment of implant-related chronic osteomyelitis is often difficult and usually consists of implant removal, extensive surgical debridement, and prolonged antibiotic use. To reduce the incidence of implant-related infections, several biomaterial surface treatments with integrated antibiotics, antiseptics, or metal ions have been developed for implants to reduce implant-related infections [44, 45]. In the current study, we developed a rat model for studies related to improve the treatment of chronic osteomyelitis.

Biofilms are universal, occurring in aquatic and indus-trial water systems as well as a large number of environ-ments and medical devices relevant for public health. Recent clinical research has implicated biofilms in the exacerbation of wounds [46, 47]. Biofilm formation, which decrease activity of antibiotics, is a crucial step in the pathogenesis of many subacute and chronic bacterial infections, including infection after artificial joints sur-gery. In this study, we developed a novel antimicrobial thermotherapy platform to treat chronic osteomyelitis. Previous studies always focused on a successful applica-tion of hyperthermia in cancer therapy [48, 49]. However, to our knowledge, this is the first in-vivo application of thermotherapy for osteomyelitis. Because of differences in the temperature sensitivity ofStaphylococcus aureus com-pared to cancer cells, transient higher temperature must be safe for realization of this technology as an effective therapeutic adjuvant for infectious pathogens. Our result showed temperature up to 75 °C is still not causing tissue damage. More important, thermotherapy may be success-fully combined with standard-of-care antibiotic treatment for polymicrobial biofilm infections and enhance anti-biotic penetration by disrupting the biofilm polysaccharide matrix. This may significantly enhance the efficacy of a given antimicrobial effect and facilitate reduced drug dose, thus providing a valuable tool for the treatment of fragile patients who cannot tolerate high dose sys-temic antibiotics.

Conclusion

In this study, we use the needle implantation and injection of methicillin-sensitive Staphylococcus aureus bacterial suspension to create an animal model of osteomyelitis

Table 1 Cierny and Mader clinical staging system for adult chronic osteomyelitis28

Anatomic type

I Medullary osteomyelitis II Superficial osteomyelitis III Localized osteomyelitis IV Diffuse osteomyelitis Physiological Class

A Good immune system and delivery B Compromised locally (BL) or systemically (BS)

C Requires suppressive or no treatment; minimal disability; treatment worse than disease; not a surgical candidate Clinical Stage

Type + Class = Clinical stage

Fig. 9 Change of relative bone volume at the affected area under different treatment modalities. Upper: Micro-CT (Computed Tomography) evaluation and radiographic examination. Lower: Systemic administration of vancomycin [VC (i.m.)] with/or without the presence of magnetic nanoparticles [VC (i.m.) + M] did not affect the bone volume change under peri-implent osteomyelitis condition; but, percent of bone volume (BV/TV) was significantly higher in the group of local administration of vancomycin into the femoral canal [VC (i.m.) + VC (f.c)] and the group when magnetic field was applied in the presence of magnetic nanoparticles [VC (i.m.) + M + IOHA]

which mimic the clinical situation as chronic infection after implantation of artificial materials. Due to biofilms decreased the efficiency of antibiotics, using systemic anti-biotic only to treat osteomyelitis did not show therapeutic difference with that of the positive control group. Here, we developed a new treatment modality to improve antibiotic efficacy in the treatment of chronic osteomye-litis. As the smaller size of magnetic naoparticles and their better dispersion in the infected surroundings, nanoparicles-induced hyperthermia can be evenly dis-tributed to the whole surface of biofilm; the biofilms could be destroyed by magnetic nanoparticles hyper-thermia and therapeutic effect of systemic antibiotics could be enhanced.

Abbreviations

BV/TV:percent bone volume; CPD: critical-point drying; EPS: extracellular polymeric substance; f.c: femur cavity injection; HE staining: hematoxylin and eosin staining; IOHA: magnetic particles hyperthermia; IONPs: iron oxide nanocrystals; M: magnetic particles; Micro-CT: Micro-Computed Tomography; MSSA: methicillin-sensitive Staphylococcus aureus; PFA: para-formaldehyde; ROS: reactive oxygen species; s.c: subcutaneous injection;

SPIOs: superparamagnetic iron oxides; TV: tissue volume; VC: vancomycin Acknowledgements

The authors wish to acknowledge thank the staff of the Second Core Lab, Department of Medical Research, National Taiwan University Hospital for technical support during the study.

Funding

The authors wish to acknowledge Industrial Technology Research Institute, Chutung, Hsinchu, Taiwan, ROC and Research Fund of National Taiwan University Hospital, Taipei, Taiwan, ROC for their funding assistance for this work. Availability of data and materials

We had supplied as a supplemental files along with the manuscript and the raw data can be accessed in the additional files.

Authors_{’ contributions}

The substantial contributions of each author was listed below:

Chih-Hsiang Fang, Pei-I Tsai, Shu-Wei Huang, Hsin-Hsin Shen, Lih-Tao Hsu, and Yen-Chun Chen:

(1) The conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content.

San-Yuan Chen, and Feng Huei Lin:

(1) The conception and design of the study, analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be submitted.

Jui-Sheng Sun, Jenny, and Zwei-Chieng Chang:

(1) The conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be submitted. Ethics approval and consent to participate

In this manuscripts no human participants, human data or human tissue are included.

The experimental protocol was approved by the Institutional Animal Care and Use Committee of Medical College, National Taiwan University (Taipei, Taiwan). Consent for publication

Not applicable. Competing interests

The authors declare that there is no benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Author details

1_{Institute of Biomedical Engineering, National Taiwan University, Taipei,}

Taiwan.2_{Department of Materials Science and Engineering, National}

Chiao-Tung University, Hsinchu 30010, Taiwan.3Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Chutung, Hsinchu 31040, Taiwan.4_{Department of Orthopedic Surgery,}

College of Medicine, National Taiwan University, No. 1, Ren-Ai Rd, Taipei 10051, Taiwan, Republic of China.5Department of Orthopedic Surgery, National Taiwan University Hospital, No.7, Chung-Shan South Rd, Taipei 10002, Taiwan, Republic of China.6_{Biomimetic Systems Research Center,}

National Chiao-Tung University, 1001 University Road, Hsinchu 300, Taiwan, Republic of China.7School of Dentistry, College of Medicine, National Taiwan University, No 1 Chang-Te Street, Taipei 10048, Taiwan.8_{Tissue Regeneration}

Product Technology Division, Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu County 310, Taiwan.9Industrial Technology Research Institute, Rm. 635, Bldg. 53, No. 195, Sec. 4, Chung Hsing Rd, Chutung, Hsinchu, Taiwan.

Received: 3 May 2017 Accepted: 19 July 2017

References

1. Gustilo RB, Merkow RL, Templeman D. The management of open fractures. J Bone Joint Surg Am. 1990;72(2):299_–304.

2. Walter G, Kemmerer M, Kappler C, Hoffmann R. Treatment algorithms for chronic osteomyelitis. Dtsch Arztebl Int. 2012;109(14):257–64.

3. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369–79. 4. Costerton JW. Biofilm theory can guide the treatment of device-related

orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.

5. Marais LC, Ferreira N, Aldous C, Le Roux TL. The outcome of treatment of chronic osteomyelitis according to an integrated approach. Strategies Trauma Limb Reconstr. 2016;11(2):135–42.

6. Shen Y, Zhu W, Chen C, Nie Y, Lin X. Biofilm formation in attached microalgal reactors. Bioprocess Biosyst Eng. 2016;39(8):1281–8.

7. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J. 2011;434(3):365_–81.

8. Aisen P, Listowsky I. Iron transport and storage proteins. Annu Rev Biochem. 1980;49:357–93.

9. Watt RK. The many faces of the octahedral ferritin protein. Biometals. 2011;24(3):489–500.

10. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319–31.

11. Lodhia J, Mandarano G, Nj F, Eu P, Cowell S. Development and use of iron oxide nanoparticles (part 1): synthesis of iron oxide nanoparticles for MRI. Biomed Imaging Interv J. 2010;6(2):e12.

12. Dutz S, Hergt R. Magnetic nanoparticle heating and heat transfer on a microscale: basic principles, realities and physical limitations of hyperthermia for tumour therapy. Int J Hyperthermia. 2013;29(8):790–800.

13. Yoshida Y, Urabe K, Furue M, Nakayama J. A case of cutaneous mycobacterium chelonae infection successfully treated with a combination of minocycline hydrochloride and thermotherapy. J Dermatol. 2004;31(2):151_–3.

14. Douple EB, Srohbehn JW, Bowers ED, Walsh JE. Cancer therapy with localized hyperthermia using an invasive microwave system. J Microw Power. 1979;14(2):181–6.

15. Strohbehn JW, Bowers ED, Walsh JE, Douple EB. An invasive microwave antenna for locally-induced hyperthermia for cancer therapy. J Microw Power. 1979;14(4):339–50.

16. Brezovich IA, Young JH. Hyperthermia with implanted electrodes. Med Phys. 1981;8(1):79_–84.

17. Yu PK, Miller J, Cringle SJ, Yu DY. Experimental retinal ablation using a fourth-harmonic 266 nm laser coupled with an optical fiber probe. Invest Ophthalmol Vis Sci. 2006r;47(4):1587–93.

18. Robins HI, Rushing D, Kutz M, Tutsch KD, Tiggelaar CL, Paul D, Spriggs D, Kraemer C, Gillis W, Feierabend C, Arzoomanian RZ, Longo W, Alberti D, d'Oleire F, Qu RP, Wilding G, Stewart JA. Phase I clinical trial of melphalan

and 41.8 degrees C whole-body hyperthermia in cancer patients. J Clin Oncol. 1997;15(1):158_–64.

19. Robins HI, Grosen E, Katschinski DM, Longo W, Tiggelaar CL, Kutz M, Winawer J, Graziano F. Whole body hyperthermia induction of soluble tumor necrosis factor receptors: implications for rheumatoid diseases. J Rheumatol. 1999;26(12):2513–6.

20. Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg. 1957;146(4):596_–606. 21. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N,

Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur Urol. 2007;52(6):1653–61.

22. Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldöfner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia. 2007;23(3):315–23.

23. Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia. 2010;26(8):790_–5. 24. Al-Hezaimi K, Ramalingam S, Al-Askar M, ArRejaie AS, Nooh N, Jawad F, Aldahmash A, Atteya M, Wang CY. Real-time-guided bone regeneration around standardized critical size calvarial defects using bone marrow-derived mesenchymal stem cells and collagen membrane with and without using tricalcium phosphate: an in vivo micro-computed tomographic and histologic experiment in rats. Int J Oral Sci. 2016;8:7–15.

25. Gao Y, Hu C, Zheng WJ, Yang S, Li F, Sun SD, Zrínyi M, Osada Y, Yang ZM, Chen YM. Fe3O4anisotropic nanostructures in Hydrogels: efficient catalysts

for the rapid removal of organic dyes from wastewater. ChemPhysChem. 2016;17(13):1999–2007.

26. Hall BB, Fitzgerald RH Jr, Rosenblatt JE. Anaerobic osteomyelitis. J Bone Joint Surg Am. 1983;65(1):30–5.

27. Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med. 1996;101(5):550–61. 28. Calhoun JH, Manring MM. Adult osteomyelitis. Infect Dis Clin North Am.

2005;19(4):765–86.

29. Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003;414(9):7–24.

30. Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia. 2002;18(4):267_–84. 31. Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, Tazawa K,

Tsukada K. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol. 2000; 16(6):1153-1158.

32. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995_–4021. 33. Ramaswamy B, Kulkarni SD, Villar PS, Smith RS, Eberly C, Araneda RC,

Depireux DA, Shapiro B. Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function. Nanomedicine. 2015;11(7):1821–9.

34. Cho H, de Jong WA, Soderquist CZ. Probing the oxygen environment in UO(2)(2+) by solid-state 17O nuclear magnetic resonance spectroscopy and relativistic density functional calculations. J Chem Phys. 2010;132(8):084501. 35. Mahendran V, Philip J. Sensing of biologically important cations such as

Na(+), K(+), ca(2+), cu(2+), and Fe(3+) using magnetic nanoemulsions. Langmuir. 2013;29(13):4252–8.

36. Elliott DW, Zhang WX. Field assessment of nanoscale bimetallic particles for groundwater treatment. Environ Sci Technol. 2001;35(24):4922–6. 37. Lahonian M, Golneshan AA. Numerical study of temperature distribution in

a spherical tissue in magnetic fluid hyperthermia using lattice Boltzmann method. IEEE Trans Nanobioscience. 2011;10(4):262–8.

38. Golneshan AA, Lahonian M. The effect of magnetic nanoparticle dispersion on temperature distribution in a spherical tissue in magnetic fluid hyperthermia using the lattice Boltzmann method. Int J Hyperthermia. 2011;27(3):266–74. 39. Lewis JA, Miller DR, Davies SG. Osteomyelitis complicating three types of

traumatic hand wound. J Wound Care. 2004;13(7):281_–3.

40. Eerenberg JP, Patka P, Haarman HJ, Dwars BJ. A new model for posttraumatic osteomyelitis in rabbits. J Invest Surg. 1994;7(5):453–65.

41. Lindsey BA, Clovis NB, Smith ES, Salihu S, Hubbard DF. An animal model for open femur fracture and osteomyelitis: part I. J Orthop Res. 2010;28(1):38_–42.

42. Lindsey BA, Clovis NB, Smith ES, Salihu S, Hubbard DF. An animal model for open femur fracture and osteomyelitis_{–part II: Immunomodulation with} systemic IL-12. J Orthop Res. 2010;28(1):43–7.

43. Subasi M, Kapukaya A, Kesemenli C, Kaya H, Sari I. Effect of granulocyte-macrophage colony-stimulating factor on treatment of acute osteomyelitis. An experimental investigation in rats. Arch Orthop Trauma Surg. 2001;121(3):170_–3. 44. Chai H, Guo L, Wang X, Fu Y, Guan J, Tan L, Ren L, Yang K. Antibacterial effect

of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo. J Mater Sci Mater Med. 2011;22(11):2525–35. 45. Ozturan KE, Yucel I, Kocoglu E, Cakici H, Guven M. Efficacy of moxifloxacin

compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. J Orthop Res. 2010t;28(10):1368–72.

46. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167_–93. 47. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease

pathogenesis. Annu Rev Microbiol. 2003;57:677–701.

48. Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A, Felix R. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol. 2006;78(1):7–14.

49. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2007;81(1):53–60.

• We accept pre-submission inquiries

• Our selector tool helps you to find the most relevant journal • We provide round the clock customer support

• Convenient online submission • Thorough peer review

• Inclusion in PubMed and all major indexing services • Maximum visibility for your research

Submit your manuscript at www.biomedcentral.com/submit

Submit your next manuscript to BioMed Central

and we will help you at every step: